Prediction Case File
YouTubeTracking Live

SOXL ETF: Friday Predicted Opening Price, 5 Target Levels After Gap-Up - Can It Hold? πŸ“ˆ

1 extracted signal Β· 0 resolved Β· 1 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
08 Oct 2026, 23:49 UTC
Recorded by Tahlil Plus
09 Oct 2026, 02:58 UTC
Video preview for SOXL ETF: Friday Predicted Opening Price, 5 Target Levels After Gap-Up - Can It Hold? πŸ“ˆ
Source overview

AI-generated source summary

The SOXL ETF is exhibiting a sell signal on the short-term Moving Average, while simultaneously showing a buy signal from the long-term Moving Average. Currently, the short-term average is above the long-term average, indicating a general buy signal with a positive forecast for the ETF. However, it faces resistance from the short-term Moving Average at approximately $156.46. On a fall, the ETF is expected to find support from the long-term average around $129.28. A breakout above the short-term average would signal a buy, while a breakdown through the long-term average would signal a sell. Additionally, a buy signal exists from the 3-month Moving Average Convergence Divergence (MACD). Some negative signals were also observed, potentially influencing near-term development. A sell signal was issued from a pivot top on Monday, October 5, 2026, with the price falling by 13.24%. Further decline is indicated until a new bottom pivot is found. Volume increased on falling prices yesterday, suggesting potential downward pressure. The 3-month outlook predicts a decline of approximately 6.22% over the next three months, with potential returns ranging from -45.60% to +7.75%. The 12-month forecast projects a change of 81.45%, with returns between 43.08% and 134.42%. The immediate target is estimated to be between $200.92 and $631.27, with a failure bound at $136.81. In the short term, the ETF can sustain continued upside and heavier volume, but it also raises two clear risks: SOXL is a 3x leveraged vehicle, so volatility and intraday re-leverage can magnify losses during pullbacks, and recent data show leveraged semis have already suffered steep selloffs and institutional trimming this quarter. Macro headwinds – higher interest rates, elevated energy prices, and tighter Fed policy – increase the odds of sharp reversals and accelerated path-dependent decay for leveraged ETFs. Over the longer term, fundamentals remain supportive: rising GPU, memory and foundry demand tied to AI could underpin semiconductor earnings and lift SOXL if secular growth persists. However, investors should view SOXL as a high-beta tactical trade, not a buy-and-hold proxy, because leverage will amplify both gains and structural downside over time.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
β€”
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.2
Tracked signals
1846
Historical success
42.5%
View full analyst profile β†’
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail